Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2024

Open Access 01-12-2024 | Artificial Intelligence | Research

Unraveling the interplay of ferroptosis and immune dysregulation in diabetic kidney disease: a comprehensive molecular analysis

Authors: Yuanyuan Jiao, Xinze Liu, Jingxuan Shi, Jiaqi An, Tianyu Yu, Guming Zou, Wenge Li, Li Zhuo

Published in: Diabetology & Metabolic Syndrome | Issue 1/2024

Login to get access

Abstract

Background

Diabetic kidney disease (DKD) is a primary microvascular complication of diabetes with limited therapeutic effects. Delving into the pathogenic mechanisms of DKD and identifying new therapeutic targets is crucial. Emerging studies reveal the implication of ferroptosis and immune dysregulation in the pathogenesis of DKD, however, the precise relationship between them remains not fully elucidated. Investigating their interplay is pivotal to unraveling the pathogenesis of diabetic kidney disease, offering insights crucial for targeted interventions and improved patient outcomes.

Methods

Integrated analysis, Consensus clustering, Machine learning including Generalized Linear Models (GLM), RandomForest (RF), Support Vector Machine (SVM) and Extreme Gradient Boosting (xGB), Artificial neural network (ANN) methods of DKD glomerular mRNA sequencing were performed to screen DKD-related ferroptosis genes.CIBERSORT, ESTIMATE and ssGSEA algorithm were used to assess the infiltration of immune cells between DKD and control groups and in two distinct ferroptosis phenotypes. The ferroptosis hub genes were verified in patients with DKD and in the db/db spontaneous type 2 diabetes mouse model via immunohistochemical and Western blotting analyses in mouse podocyte MPC5 and mesangial SV40-MES-13 cells under high-glucose (HG) conditions.

Results

We obtained 16 differentially expressed ferroptosis related genes and patients with DKD were clustered into two subgroups by consensus clustering. Five ferroptosis genes (DUSP1,ZFP36,PDK4,CD44 and RGS4) were identified to construct a diagnostic model with a good diagnosis performance in external validation. Analysis of immune infiltration revealed immune heterogeneity between DKD patients and controls.Moreover, a notable differentiation in immune landscape, comprised of Immune cells, ESTIMATE Score, Immune Score and Stromal Score was observed between two FRG clusters. GSVA analysis indicated that autophagy, apoptosis and complement activation can participate in the regulation of ferroptosis phenotypes. Experiment results showed that ZFP36 was significantly overexpressed in both tissue and cells while CD44 was on the contrary.Meanwhile,spearman analysis showed both ZFP36 and CD44 has a strong correlation with different immune cells,especially macrophage.

Conclusion

The regulation of the immune landscape in DKD is significantly influenced by the focal point on ferroptosis. Newly identified ferroptosis markers, CD44 and ZFP36, are poised to play essential roles through their interactions with macrophages, adding substantial value to this regulatory landscape.
Appendix
Available only for authorised users
Literature
1.
go back to reference GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.CrossRef
3.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in chronic kidney disease. Kidney Int. 2022;102(5S):S1–127. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in chronic kidney disease. Kidney Int. 2022;102(5S):S1–127.
4.
go back to reference Bayır H, Dixon SJ, Tyurina YY, Kellum JA, Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023;19(5):315–36.PubMedCrossRef Bayır H, Dixon SJ, Tyurina YY, Kellum JA, Kagan VE. Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023;19(5):315–36.PubMedCrossRef
5.
go back to reference Zhou Y, Zhang J, Guan Q, Tao X, Wang J, Li W. The role of ferroptosis in the development of acute and chronic kidney diseases. J Cell Physiol. 2022;237(12):4412–27.PubMedCrossRef Zhou Y, Zhang J, Guan Q, Tao X, Wang J, Li W. The role of ferroptosis in the development of acute and chronic kidney diseases. J Cell Physiol. 2022;237(12):4412–27.PubMedCrossRef
10.
11.
go back to reference Wang Y, Bi R, Quan F, et al. Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur J Pharmacol. 2020;888:173574.PubMedCrossRef Wang Y, Bi R, Quan F, et al. Ferroptosis involves in renal tubular cell death in diabetic nephropathy. Eur J Pharmacol. 2020;888:173574.PubMedCrossRef
12.
go back to reference Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–49.PubMedCrossRef Li S, Zheng L, Zhang J, Liu X, Wu Z. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–49.PubMedCrossRef
13.
go back to reference Zhang Q, Hu Y, Hu JE, et al. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis. Life Sci. 2021;278:119529.PubMedCrossRef Zhang Q, Hu Y, Hu JE, et al. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis. Life Sci. 2021;278:119529.PubMedCrossRef
14.
go back to reference Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–96.PubMedCrossRef Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–96.PubMedCrossRef
16.
go back to reference Hsu SK, Li CY, Lin IL, et al. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11(18):8813–35.PubMedPubMedCentralCrossRef Hsu SK, Li CY, Lin IL, et al. Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment. Theranostics. 2021;11(18):8813–35.PubMedPubMedCentralCrossRef
17.
go back to reference Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K. Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60(9):2354–69.PubMedPubMedCentralCrossRef Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K. Transcriptome analysis of human diabetic kidney disease. Diabetes. 2011;60(9):2354–69.PubMedPubMedCentralCrossRef
18.
go back to reference Grayson PC, Eddy S, Taroni JN, Lightfoot YL, Mariani L, Parikh H, Lindenmeyer MT, et al. Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis. 2018;77(8):1226–33.PubMed Grayson PC, Eddy S, Taroni JN, Lightfoot YL, Mariani L, Parikh H, Lindenmeyer MT, et al. Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis. 2018;77(8):1226–33.PubMed
19.
go back to reference Pan Y, Jiang S, Hou Q, et al. Dissection of glomerular Transcriptional Profile in patients with Diabetic Nephropathy: SRGAP2a protects Podocyte structure and function. Diabetes. 2018;67(4):717–30.PubMedCrossRef Pan Y, Jiang S, Hou Q, et al. Dissection of glomerular Transcriptional Profile in patients with Diabetic Nephropathy: SRGAP2a protects Podocyte structure and function. Diabetes. 2018;67(4):717–30.PubMedCrossRef
20.
21.
go back to reference Fan Y, Yi Z, D’Agati VD, et al. Comparison of kidney transcriptomic profiles of early and Advanced Diabetic Nephropathy reveals potential New mechanisms for Disease Progression. Diabetes. 2019;68(12):2301–14.PubMedPubMedCentralCrossRef Fan Y, Yi Z, D’Agati VD, et al. Comparison of kidney transcriptomic profiles of early and Advanced Diabetic Nephropathy reveals potential New mechanisms for Disease Progression. Diabetes. 2019;68(12):2301–14.PubMedPubMedCentralCrossRef
22.
go back to reference Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, Ning Y, Peng L. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51(D1):D571–82.PubMedCrossRef Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, Ning Y, Peng L. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2023;51(D1):D571–82.PubMedCrossRef
23.
go back to reference Lindsey JK. A review of some extensions to generalized linear models. Stat Med. 1999;18(17–18):2223–36.PubMedCrossRef Lindsey JK. A review of some extensions to generalized linear models. Stat Med. 1999;18(17–18):2223–36.PubMedCrossRef
25.
go back to reference Tan M, Pu J, Zheng B. Optimization of breast mass classification using sequential forward floating selection (SFFS) and a support vector machine (SVM) model. Int J Comput Assist Radiol Surg. 2014;9(6):1005–20.PubMedPubMedCentralCrossRef Tan M, Pu J, Zheng B. Optimization of breast mass classification using sequential forward floating selection (SFFS) and a support vector machine (SVM) model. Int J Comput Assist Radiol Surg. 2014;9(6):1005–20.PubMedPubMedCentralCrossRef
26.
go back to reference Chen T, Guestrin C, XGBoost. A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; August 13–17, 2016, San Francisco, California. ACM, 2016; pp.785–94. Chen T, Guestrin C, XGBoost. A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; August 13–17, 2016, San Francisco, California. ACM, 2016; pp.785–94.
27.
go back to reference Timmerman ME, Ceulemans E, De Roover K, Van Leeuwen K. Subspace K-means clustering. Behav Res Methods. 2013;45(4):1011–23.PubMedCrossRef Timmerman ME, Ceulemans E, De Roover K, Van Leeuwen K. Subspace K-means clustering. Behav Res Methods. 2013;45(4):1011–23.PubMedCrossRef
28.
go back to reference Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.PubMedPubMedCentralCrossRef Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.PubMedPubMedCentralCrossRef
30.
go back to reference Jia Q, Wu W, Wang Y, et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9(1):5361.PubMedPubMedCentralCrossRef Jia Q, Wu W, Wang Y, et al. Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9(1):5361.PubMedPubMedCentralCrossRef
31.
go back to reference He Y, Jiang Z, Chen C, Wang X. Classification of triple-negative breast cancers based on immunogenomic profiling. J Exp Clin Cancer Res. 2018;37(1):327.PubMedPubMedCentralCrossRef He Y, Jiang Z, Chen C, Wang X. Classification of triple-negative breast cancers based on immunogenomic profiling. J Exp Clin Cancer Res. 2018;37(1):327.PubMedPubMedCentralCrossRef
32.
33.
go back to reference Wu Y, Zhao Y, Yang HZ, Wang YJ, Chen Y. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose. Biosci Rep. 2021;41(2):BSR20202924.PubMedPubMedCentralCrossRef Wu Y, Zhao Y, Yang HZ, Wang YJ, Chen Y. HMGB1 regulates ferroptosis through Nrf2 pathway in mesangial cells in response to high glucose. Biosci Rep. 2021;41(2):BSR20202924.PubMedPubMedCentralCrossRef
34.
go back to reference Zhou L, Xue X, Hou Q, Dai C. Targeting ferroptosis attenuates interstitial inflammation and kidney fibrosis. Kidney Dis (Basel). 2021;8(1):57–71.PubMedCrossRef Zhou L, Xue X, Hou Q, Dai C. Targeting ferroptosis attenuates interstitial inflammation and kidney fibrosis. Kidney Dis (Basel). 2021;8(1):57–71.PubMedCrossRef
35.
go back to reference Dou J, Liu X, Yang L, Huang D, Tan X. Ferroptosis interaction with inflammatory microenvironments: mechanism, biology, and treatment. Biomed Pharmacother. 2022;155:113711.PubMedCrossRef Dou J, Liu X, Yang L, Huang D, Tan X. Ferroptosis interaction with inflammatory microenvironments: mechanism, biology, and treatment. Biomed Pharmacother. 2022;155:113711.PubMedCrossRef
36.
go back to reference Zhang X, Chao P, Zhang L, et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198.PubMedPubMedCentralCrossRef Zhang X, Chao P, Zhang L, et al. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease. Front Immunol. 2023;14:1030198.PubMedPubMedCentralCrossRef
37.
go back to reference Fu J, Sun Z, Wang X, et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022;102(6):1291–304.PubMedPubMedCentralCrossRef Fu J, Sun Z, Wang X, et al. The single-cell landscape of kidney immune cells reveals transcriptional heterogeneity in early diabetic kidney disease. Kidney Int. 2022;102(6):1291–304.PubMedPubMedCentralCrossRef
39.
go back to reference Jiandong L, Yang Y, Peng J, et al. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomed Pharmacother. 2019;109:93–102.PubMedCrossRef Jiandong L, Yang Y, Peng J, et al. Trichosanthes kirilowii lectin ameliorates streptozocin-induced kidney injury via modulation of the balance between M1/M2 phenotype macrophage. Biomed Pharmacother. 2019;109:93–102.PubMedCrossRef
40.
42.
go back to reference Zhang Y, Li NF, Abulikemu S, et al. Relationship between zinc finger protein 36 (ZFP36) gene polymorphisms and obstructive sleep apnea. Genet Mol Res. 2015;14(2):6733–43.PubMedCrossRef Zhang Y, Li NF, Abulikemu S, et al. Relationship between zinc finger protein 36 (ZFP36) gene polymorphisms and obstructive sleep apnea. Genet Mol Res. 2015;14(2):6733–43.PubMedCrossRef
43.
go back to reference Zhang Z, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020;16(8):1482–505.PubMedCrossRef Zhang Z, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020;16(8):1482–505.PubMedCrossRef
44.
go back to reference Weng X, Maxwell-Warburton S, Hasib A, Ma L, Kang L. The membrane receptor CD44: novel insights into metabolism. Trends Endocrinol Metab. 2022;33(5):318–32.PubMedCrossRef Weng X, Maxwell-Warburton S, Hasib A, Ma L, Kang L. The membrane receptor CD44: novel insights into metabolism. Trends Endocrinol Metab. 2022;33(5):318–32.PubMedCrossRef
45.
go back to reference Bian Z, Sun X, Liu L, et al. Sodium Butyrate induces CRC Cell Ferroptosis via the CD44/SLC7A11 pathway and exhibits a synergistic therapeutic effect with Erastin. Cancers (Basel). 2023;15(2):423.PubMedCrossRef Bian Z, Sun X, Liu L, et al. Sodium Butyrate induces CRC Cell Ferroptosis via the CD44/SLC7A11 pathway and exhibits a synergistic therapeutic effect with Erastin. Cancers (Basel). 2023;15(2):423.PubMedCrossRef
46.
47.
go back to reference Chebotareva N, Vinogradov A, Tsoy L, et al. CD44 expression in renal tissue is Associated with an increase in urinary levels of Complement Components in Chronic glomerulopathies. Int J Mol Sci. 2023;24(8):7190.PubMedPubMedCentralCrossRef Chebotareva N, Vinogradov A, Tsoy L, et al. CD44 expression in renal tissue is Associated with an increase in urinary levels of Complement Components in Chronic glomerulopathies. Int J Mol Sci. 2023;24(8):7190.PubMedPubMedCentralCrossRef
Metadata
Title
Unraveling the interplay of ferroptosis and immune dysregulation in diabetic kidney disease: a comprehensive molecular analysis
Authors
Yuanyuan Jiao
Xinze Liu
Jingxuan Shi
Jiaqi An
Tianyu Yu
Guming Zou
Wenge Li
Li Zhuo
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2024
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-024-01316-w

Other articles of this Issue 1/2024

Diabetology & Metabolic Syndrome 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.